<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37654669</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>The effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort study.</ArticleTitle><Pagination><StartPage>102086</StartPage><MedlinePgn>102086</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102086</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2023.102086</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Cognitive impairment has been reported after many types of infection, including SARS-CoV-2. Whether deficits following SARS-CoV-2 improve over time is unclear. Studies to date have focused on hospitalised individuals with up to a year follow-up. The presence, magnitude, persistence and correlations of effects in community-based cases remain relatively unexplored.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Cognitive performance (working memory, attention, reasoning, motor control) was assessed in a prospective cohort study of participants from the United Kingdom COVID Symptom Study Biobank between July 12, 2021 and August 27, 2021 (Round 1), and between April 28, 2022 and June 21, 2022 (Round 2). Participants, recruited from the COVID Symptom Study smartphone app, comprised individuals with and without SARS-CoV-2 infection and varying symptom duration. Effects of COVID-19 exposures on cognitive accuracy and reaction time scores were estimated using multivariable ordinary least squares linear regression models weighted for inverse probability of participation, adjusting for potential confounders and mediators. The role of ongoing symptoms after COVID-19 infection was examined stratifying for self-perceived recovery. Longitudinal analysis assessed change in cognitive performance between rounds.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">3335 individuals completed Round 1, of whom 1768 also completed Round 2. At Round 1, individuals with previous positive SARS-CoV-2 tests had lower cognitive accuracy (N&#xa0;=&#xa0;1737, &#x3b2;&#xa0;=&#xa0;-0.14 standard deviations, SDs, 95% confidence intervals, CI:&#xa0;-0.21,&#xa0;-0.07) than negative controls. Deficits were largest for positive individuals with &#x2265;12 weeks of symptoms (N&#xa0;=&#xa0;495, &#x3b2;&#xa0;=&#xa0;-0.22 SDs, 95% CI:&#xa0;-0.35,&#xa0;-0.09). Effects were comparable to hospital presentation during illness (N&#xa0;=&#xa0;281, &#x3b2;&#xa0;=&#xa0;-0.31 SDs, 95% CI:&#xa0;-0.44,&#xa0;-0.18), and 10 years age difference (60-70 years vs. 50-60 years, &#x3b2;&#xa0;=&#xa0;-0.21 SDs, 95% CI:&#xa0;-0.30,&#xa0;-0.13) in the whole study population. Stratification by self-reported recovery revealed that deficits were only detectable in SARS-CoV-2 positive individuals who did not feel recovered from COVID-19, whereas individuals who reported full recovery showed no deficits. Longitudinal analysis showed no evidence of cognitive change over time, suggesting that cognitive deficits for affected individuals persisted at almost 2 years since initial infection.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">Cognitive deficits following SARS-CoV-2 infection were detectable nearly two years post infection, and largest for individuals with longer symptom durations, ongoing symptoms, and/or more severe infection. However, no such deficits were detected in individuals who reported full recovery from COVID-19. Further work is needed to monitor and develop understanding of recovery mechanisms for those with ongoing symptoms.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">Chronic Disease Research Foundation, Wellcome Trust, National Institute for Health and Care Research, Medical Research Council, British Heart Foundation, Alzheimer's Society, European Union, COVID-19 Driver Relief Fund, French National Research Agency.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheetham</LastName><ForeName>Nathan J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penfold</LastName><ForeName>Rose</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Edinburgh Delirium Research Group, Ageing and Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giunchiglia</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Brain Sciences, Imperial College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowyer</LastName><ForeName>Vicky</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sudre</LastName><ForeName>Carole H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>MRC Unit for Lifelong Health and Ageing, Department of Population Health Sciences, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Medical Image Computing, Department of Computer Science, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canas</LastName><ForeName>Liane S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerfoot</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rjoob</LastName><ForeName>Khaled</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>MRC Unit for Lifelong Health and Ageing, Department of Population Health Sciences, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molteni</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;sterdahl</LastName><ForeName>Marc F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harvey</LastName><ForeName>Nicholas R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trender</LastName><ForeName>William R</ForeName><Initials>WR</Initials><AffiliationInfo><Affiliation>Department of Brain Sciences, Imperial College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malim</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doores</LastName><ForeName>Katie J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hellyer</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Centre for Neuroimaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modat</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammers</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College London &amp; Guy's and St Thomas' PET Centre, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ourselin</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>Emma L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guy's &amp; St Thomas's NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hampshire</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Brain Sciences, Imperial College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steves</LastName><ForeName>Claire J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guy's &amp; St Thomas's NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/W005611/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 recovery</Keyword><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>NJC is supported by NIHR via their institution; CHS is supported by Alzheimer's Society via their institution and is Scientific Advisor to BrainKey; WRT is a part time employee H2 Cognitive Designs, who market the online testing platform used in this study; PJH is the Chief Executive and Co-founder of H2 Cognitive Designs LTD, who market the online testing platform used in this study; M. Modat reports funding support from UK Department of Health and Social Care, UKRI, EPSRC and Wellcome Trust via their institution; SO is supported by French National Research Agency, Wellcome Trust, EPSRC and UK Department of Health and Social Care; A. Hampshire is an owner/director of Future Cognition Ltd and co-owner and co-director of H2 Cognitive Designs, which provide cognitive assessment services and software for third parties; CJS is supported by UKRI, Wellcome Trust and Chronic Disease Research Foundation via their institution, and declares a consultancy contract with ZOE Ltd. All other authors make no disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37654669</ArticleId><ArticleId IdType="pmc">PMC10466229</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2023.102086</ArticleId><ArticleId IdType="pii">S2589-5370(23)00263-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ceban F., Ling S., Lui L.M.W., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93&#x2013;135. doi: 10.1016/J.BBI.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBI.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L., Palmer K., Calandri I., et al. Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement. 2022;18(5):1047&#x2013;1066. doi: 10.1002/ALZ.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ALZ.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Houben S., Bonnech&#xe8;re B. The impact of COVID-19 infection on cognitive function and the implication for rehabilitation: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(13):7748. doi: 10.3390/ijerph19137748.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19137748</ArticleId><ArticleId IdType="pmc">PMC9266128</ArticleId><ArticleId IdType="pubmed">35805406</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn N., Mullee M., Perry H., Holmes C. Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis Assoc Disord. 2005;19(2):91&#x2013;94. doi: 10.1097/01.WAD.0000165511.52746.1F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.WAD.0000165511.52746.1F</ArticleId><ArticleId IdType="pubmed">15942327</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah F.A., Pike F., Alvarez K., et al. Bidirectional relationship between cognitive function and pneumonia. Am J Respir Crit Care Med. 2013;188(5):586&#x2013;592. doi: 10.1164/RCCM.201212-2154OC/SUPPL_FILE/DISCLOSURES.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/RCCM.201212-2154OC/SUPPL_FILE/DISCLOSURES</ArticleId><ArticleId IdType="pmc">PMC3827700</ArticleId><ArticleId IdType="pubmed">23848267</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., et al. Cognitive deficits in people who have recovered from COVID-19. eClinicalMedicine. 2021;39(0) doi: 10.1016/j.eclinm.2021.101044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Chatfield D.A., Mphil A.M., et al. Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. eClinicalMedicine. 2022;47 doi: 10.1016/J.ECLINM.2022.101417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ECLINM.2022.101417</ArticleId><ArticleId IdType="pmc">PMC9048584</ArticleId><ArticleId IdType="pubmed">35505938</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E.J., Ren A.L., Digby R.J., et al. Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain. 2022;145(11):4097&#x2013;4107. doi: 10.1093/brain/awac321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac321</ArticleId><ArticleId IdType="pmc">PMC9494359</ArticleId><ArticleId IdType="pubmed">36065116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE. https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Post COVID-19 condition (long COVID) https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition</Citation></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0/ATTACHMENT/EC2562F1-0A0D-4F99-8E17-637EC38A98F3/MMC2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0/ATTACHMENT/EC2562F1-0A0D-4F99-8E17-637EC38A98F3/MMC2</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>ONS  Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 2 February 2023 - Office for National Statistics. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2february2023</Citation></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;1085. doi: 10.1002/ACN3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ACN3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie C.E., Lowe D.J., McAuley A., et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13(1):5663. doi: 10.1038/s41467-022-33415-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33415-5</ArticleId><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38 doi: 10.1016/J.ECLINM.2021.101019/ATTACHMENT/499C606A-AE36-49F5-87DD-09E3B87369C9/MMC1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ECLINM.2021.101019/ATTACHMENT/499C606A-AE36-49F5-87DD-09E3B87369C9/MMC1</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., Leavy O.C., Richardson M., et al. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Canas L.S., Molteni E., Deng J., et al. Profiling post-COVID syndrome across different variants of SARS-CoV-2. medRxiv. 2022 doi: 10.1101/2022.07.28.22278159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.07.28.22278159</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9(10):815&#x2013;827. doi: 10.1016/s2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2021;22(1):43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooker H., Williams G., Hampshire A., et al. FLAME: a computerized neuropsychological composite for trials in early dementia. Alzheimers Dement. 2020;12(1) doi: 10.1002/dad2.12098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dad2.12098</ArticleId><ArticleId IdType="pmc">PMC7560493</ArticleId><ArticleId IdType="pubmed">33088895</ArticleId></ArticleIdList></Reference><Reference><Citation>Creese B., Brooker H., Ismail Z., et al. Mild behavioral impairment as a marker of cognitive decline in cognitively normal older adults. Am J Geriatr Psychiatry. 2019;27(8):823&#x2013;834. doi: 10.1016/J.JAGP.2019.01.215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JAGP.2019.01.215</ArticleId><ArticleId IdType="pubmed">30902566</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart G.R., Corbett A., Ballard C., et al. The cognitive profile of middle-aged and older adults with high vs. low autistic traits. Autism Res. 2022;16:1&#x2013;12. doi: 10.1002/aur.2866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aur.2866</ArticleId><ArticleId IdType="pmc">PMC10947177</ArticleId><ArticleId IdType="pubmed">36454212</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen A.M., Hampshire A., Grahn J.A., et al. Putting brain training to the test. Nature. 2010;465(7299):775&#x2013;778. doi: 10.1038/nature09042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09042</ArticleId><ArticleId IdType="pmc">PMC2884087</ArticleId><ArticleId IdType="pubmed">20407435</ArticleId></ArticleIdList></Reference><Reference><Citation>Peers P.V., Punton S.F., Murphy F.C., et al. A&#xa0;randomized control trial of the effects of home-based online attention training and working memory training on cognition and everyday function in a&#xa0;community stroke sample. Neuropsychol Rehabil. 2022;32(10):2603&#x2013;2627. doi: 10.1080/09602011.2021.1972817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09602011.2021.1972817</ArticleId><ArticleId IdType="pmc">PMC7615301</ArticleId><ArticleId IdType="pubmed">34505555</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolly A.E., Scott G.T., Sharp D.J., Hampshire A.H. Distinct patterns of structural damage underlie working memory and reasoning deficits after traumatic brain injury. Brain. 2020;143(4):1158&#x2013;1176. doi: 10.1093/brain/awaa067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa067</ArticleId><ArticleId IdType="pmc">PMC7174032</ArticleId><ArticleId IdType="pubmed">32243506</ArticleId></ArticleIdList></Reference><Reference><Citation>Levis B., Benedetti A., Thombs B.D. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365 doi: 10.1136/BMJ.L1476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.L1476</ArticleId><ArticleId IdType="pmc">PMC6454318</ArticleId><ArticleId IdType="pubmed">30967483</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer R.L., Kroenke K., Williams J.B.W., L&#xf6;we B. A&#xa0;brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092&#x2013;1097. doi: 10.1001/ARCHINTE.166.10.1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/ARCHINTE.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T., Berelowitz G., Pawlikowska T., et al. Development of a fatigue scale. J&#xa0;Psychosom Res. 1993;37(2):147&#x2013;153. doi: 10.1016/0022-3999(93)90081-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-P</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella M., Chalder T. Measuring fatigue in clinical and community settings. J&#xa0;Psychosom Res. 2010;69(1):17&#x2013;22. doi: 10.1016/J.JPSYCHORES.2009.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JPSYCHORES.2009.10.007</ArticleId><ArticleId IdType="pubmed">20630259</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundt J.C., Marks I.M., Shear M.K., Greist J.H. The work and social adjustment scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180(5):461&#x2013;464. doi: 10.1192/BJP.180.5.461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/BJP.180.5.461</ArticleId><ArticleId IdType="pubmed">11983645</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R.L., Williams J.B.W., L&#xf6;we B. An ultra-brief screening scale for anxiety and depression: the PHQ&#x2013;4. Psychosomatics. 2009;50(6):613&#x2013;621. doi: 10.1016/S0033-3182(09)70864-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0033-3182(09)70864-3</ArticleId><ArticleId IdType="pubmed">19996233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ra&#xee;che M., H&#xe9;bert R., Dubois M.F. PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities. Arch Gerontol Geriatr. 2008;47(1):9&#x2013;18. doi: 10.1016/J.ARCHGER.2007.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ARCHGER.2007.06.004</ArticleId><ArticleId IdType="pubmed">17723247</ArticleId></ArticleIdList></Reference><Reference><Citation>English indices of deprivation 2019 - GOV.UK. https://www.gov.uk/government/statistics/english-indices-of-deprivation-2019</Citation></Reference><Reference><Citation>Murray B., Kerfoot E., Chen L., et al. Accessible data curation and analytics for international-scale citizen science datasets. Sci Data. 2021;8(1):1&#x2013;17. doi: 10.1038/s41597-021-01071-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-021-01071-x</ArticleId><ArticleId IdType="pmc">PMC8608807</ArticleId><ArticleId IdType="pubmed">34811392</ArticleId></ArticleIdList></Reference><Reference><Citation>Seow J., Graham C., Merrick B., et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020;5(12):1598&#x2013;1607. doi: 10.1038/s41564-020-00813-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00813-8</ArticleId><ArticleId IdType="pmc">PMC7610833</ArticleId><ArticleId IdType="pubmed">33106674</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith G.J., Morris T.T., Tudball M.J., et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11(1):1&#x2013;12. doi: 10.1038/s41467-020-19478-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19478-2</ArticleId><ArticleId IdType="pmc">PMC7665028</ArticleId><ArticleId IdType="pubmed">33184277</ArticleId></ArticleIdList></Reference><Reference><Citation>Minka T.P. 2000. Automatic choice of dimensionality for PCA.</Citation></Reference><Reference><Citation>Textor J., van der Zander B., Gilthorpe M.S., Li&#x15b;kiewicz M., Ellison G.T. Robust causal inference using directed acyclic graphs: the R package &#x2018;dagitty&#x2019;. Int J Epidemiol. 2017;45(6) doi: 10.1093/ije/dyw341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw341</ArticleId><ArticleId IdType="pubmed">28089956</ArticleId></ArticleIdList></Reference><Reference><Citation>Westreich D., Greenland S. The table&#xa0;2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol. 2013;177(4):292&#x2013;298. doi: 10.1093/AJE/KWS412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/AJE/KWS412</ArticleId><ArticleId IdType="pmc">PMC3626058</ArticleId><ArticleId IdType="pubmed">23371353</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennant P.W.G., Arnold K.F., Ellison G.T.H., Gilthorpe M.S. Analyses of &#x2018;change scores&#x2019; do not estimate causal effects in observational data. Int J Epidemiol. 2021;51(5):1604&#x2013;1615. doi: 10.1093/IJE/DYAB050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/IJE/DYAB050</ArticleId><ArticleId IdType="pmc">PMC9557845</ArticleId><ArticleId IdType="pubmed">34100077</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y., Hochberg Y. Controlling the false discovery rate: a&#xa0;practical and powerful approach to multiple testing. J&#xa0;R Stat Soc. 1995;57(1):289&#x2013;300. doi: 10.1111/J.2517-6161.1995.TB02031.X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.2517-6161.1995.TB02031.X</ArticleId></ArticleIdList></Reference><Reference><Citation>Christ B.U., Combrinck M.I., Thomas K.G.F. Both reaction time and accuracy measures of intraindividual variability predict cognitive performance in Alzheimer's disease. Front Hum Neurosci. 2018;12:124. doi: 10.3389/FNHUM.2018.00124/FULL.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNHUM.2018.00124/FULL</ArticleId><ArticleId IdType="pmc">PMC5900796</ArticleId><ArticleId IdType="pubmed">29686610</ArticleId></ArticleIdList></Reference><Reference><Citation>Bielak A.A.M., Hultsch D.F., Strauss E., MacDonald S.W.S., Hunter M.A. Intraindividual variability in reaction time predicts cognitive outcomes 5 years later. Neuropsychology. 2010;24(6):731&#x2013;741. doi: 10.1037/A0019802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/A0019802</ArticleId><ArticleId IdType="pubmed">20853957</ArticleId></ArticleIdList></Reference><Reference><Citation>Graveson J., Bauermeister S., McKeown D., Bunce D. Intraindividual reaction time variability, falls, and gait in old age: a systematic review. J&#xa0;Gerontol B Psychol Sci Soc Sci. 2016;71(5):857&#x2013;864. doi: 10.1093/GERONB/GBV027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/GERONB/GBV027</ArticleId><ArticleId IdType="pubmed">25969471</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Benito Ballesteros A., Yeung S.P., et al. COVCOG 2: cognitive and memory deficits in long COVID: a second publication from the COVID and cognition study. Front Aging Neurosci. 2022;14:204. doi: 10.3389/FNAGI.2022.804937/BIBTEX.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNAGI.2022.804937/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8967943</ArticleId><ArticleId IdType="pubmed">35370620</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Porcher R., Pane I., Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13(1):1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kl&#xe4;ser K., Molteni E., Graham M., et al. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study. Sci Rep. 2022;12(1) doi: 10.1038/s41598-022-14016-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-14016-0</ArticleId><ArticleId IdType="pmc">PMC9240087</ArticleId><ArticleId IdType="pubmed">35764879</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.J., MacKenna B., Inglesby P., et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract. 2021;71(712):495. doi: 10.3399/BJGP.2021.0301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0301</ArticleId><ArticleId IdType="pmc">PMC8544137</ArticleId><ArticleId IdType="pubmed">34711574</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>